View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
December 11, 2017

Chinese consortium to acquire Italy’s Esaote

A Chinese consortium comprising medical technology and healthcare firms, and financial investors, has signed a definitive agreement to purchase the entire share capital of Italy-based medical equipment maker Esaote.

A Chinese consortium comprising medical technology and healthcare firms, and financial investors, has signed a definitive agreement to purchase the entire share capital of Italy-based medical equipment maker Esaote.

The transaction involves all of Esaote’s outstanding shares, including those held by Ares Life Sciences, NB Renaissance Partners, Value Italy, Equinox, Carlo Castellano, and Carige.

The deal is said to aid Esaote’s growth by offering improved access to the growing medical equipment market in the country.

In parallel, the consortium would leverage Esaote’s research and development (R&D) capabilities, product portfolio and international distribution network for the medical imaging industry.

Following the completion of the acquisition, the company will function as an independent entity and will continue its R&D and manufacturing activities in Italy and the Netherlands.

“The deal is said to aid Esaote’s growth by offering improved access to the growing medical equipment market in the country.”

Esaote CEO Karl-Heinz Lumpi said: “We look forward to learning from and leveraging their deep knowledge and experience of the Chinese market where the potential for growth is significant, especially considering that the ultrasound sector alone is worth nearly €1.3bn in China.”

After the transaction, which is estimated to close next year, Lumpi will continue to lead Esaote.

The consortium purchasing the firm includes Beijing Wandong Medical Technology, Jiangsu Yuyue Science and Technology Development, Shanghai Yunfeng Xinchuang Investment Management, Shanghai FTZ Fund Management, Shanghai Kangda Medical Equipment Group, and Shanghai Tianyi Industries.

While the consortium will bolster Esaote’s Chinese presence through Wandong, Yuwell, Meinian, and Kangda distribution networks, the company will market the consortium’s relevant products in other markets within its reach.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU